ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,186Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 337

$503K Total Retail Price of All Prescriptions

Rank: 76 out of 337

446 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 9,253 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 991 945 1 3
SIMVASTATIN 493 426 2 1
OMEPRAZOLE 449 339 3 4
LISINOPRIL 398 339 4 2
LOSARTAN POTASSIUM 283 255 5 15
HYDROCODONE-ACETAMINOPHEN 268 174 S3 6 13
PRAVASTATIN SODIUM 230 204 7 14
METOPROLOL TARTRATE 229 211 8 6
LEVOTHYROXINE SODIUM 226 205 9 5
WARFARIN SODIUM 201 171 10 11
ATORVASTATIN CALCIUM 195 182 11 7
SERTRALINE HCL 177 138 12 18
TRAZODONE HCL 172 148 13 16
ATENOLOL 171 157 14 10
HYDROCHLOROTHIAZIDE 170 167 15 9
CITALOPRAM HBR 163 117 16 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 153 120 17 31
FUROSEMIDE 141 114 18 8
TRAMADOL HCL 139 121 19 32
ZOLPIDEM TARTRATE 118 92 20 23
LOSARTAN-HYDROCHLOROTHIAZIDE 114 90 21 60
LIPITOR 109 104 22 33
OXYCODONE-ACETAMINOPHEN 107 107 S2 23 84
METFORMIN HCL 105 77 24 12
GLYBURIDE-METFORMIN HCL 98 84 R 25 99
NEXIUM 95 50 26 56
PROAIR HFA 93 53 27 38
GABAPENTIN 91 76 28 20
MIRTAZAPINE 89 74 29 27
LOVASTATIN 88 76 30 24
TAMSULOSIN HCL 85 61 31 25
BUMETANIDE 82 59 32 163
FLUTICASONE PROPIONATE 82 31 32 34
SYNTHROID 80 66 34 41
IBUPROFEN 79 40 35 64
DIOVAN 77 77 36 26
HYDRALAZINE HCL 75 75 37 122
MELOXICAM 70 58 38 54
NAMENDA 67 67 39 35
OXYBUTYNIN CHLORIDE 66 52 40 143
DOXAZOSIN MESYLATE 65 52 41 68
ALENDRONATE SODIUM 65 45 41 19
METFORMIN HCL ER 65 65 41 52
CARVEDILOL 64 52 44 73
CRESTOR 62 62 45 29
DONEPEZIL HCL 62 62 45 22
PANTOPRAZOLE SODIUM 61 56 47 36
RISPERIDONE 61 34 47 72
PLAVIX 60 60 49 74
NAPROXEN 58 36 50 98
GLIPIZIDE ER 52 50 51 69
FINASTERIDE 52 50 51 83
DIOVAN HCT 51 51 53 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.